Skip to content
AwardedSpainGoodsFramework agreement€86,779,166

Suministro sucesivo del medicamento "CILTACABTAGEN AUTOLEUCEL"

Published
Published 5 June 2026

Overview

The Área Sanitaria da Coruña e Cee has awarded a successive supply contract for the medicinal product CILTACABTAGEN AUTOLEUCEL to JANSSEN-CILAG, S.A. on 25 May 2026 under framework agreement lot 2 MA-SER1-25-038. The estimated value of the procurement is approximately 86.8 million EUR.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€86,779,166
Procedure
Direct
Contract type
Framework agreement
Published
5 June 2026
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
€0
Award date
25 May 2026
Contract period
26 May 2026 → 25 July 2030
Winner
  • JANSSEN-CILAG, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    5 June 2026

Contracting authority

  • Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud

    Procuring entity

    A Coruña, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro sucesivo del medicamento "CILTACABTAGEN AUTOLEUCEL" — won by JANSSEN-CILAG, S.A. — Skim